news flash·2025-07-04 07:47Market Overview - A total of 39 stocks hit the daily limit up, with 10 stocks on consecutive limit up boards, including 3 stocks with three consecutive limit ups or more [1] - The upgrade rate for consecutive limit up stocks is 21.42%, excluding ST and delisted stocks [1] - Over 4,100 stocks in the market declined, indicating a renewed decrease in market risk appetite [1] Individual Stock Performance - Chengbang Co. experienced a significant drop in the afternoon, turning from green to red, contributing to a decline in the overall limit up stock performance [1] - The highest number of consecutive limit up stocks fell to 4 [1] - Among the 14 limit up stocks from the previous day, only 3 advanced, while 4 stocks hit the daily limit down and 2 stocks fell over 9% [1] Sector Performance - The banking sector showed strong performance throughout the day, with CITIC Bank, Industrial Bank, and Everbright Bank each rising over 3% [1] - Several banks, including CITIC Bank, Industrial Bank, Shanghai Pudong Development Bank, Beijing Bank, and Shanghai Bank, reached historical highs [1] Pharmaceutical Sector - Continuous positive news in the innovative drug sector, with Dize Pharmaceutical's Shuwozhe becoming the first independently developed global innovative drug approved in the U.S. [1] - Concept stocks in this sector continued to strengthen, with Sairui Medical achieving four consecutive limit ups, and Weixin Kang and Guosheng Tang achieving two consecutive limit ups [1] - Rejing Biological hit the daily limit up of 20% [1]